IUPEI Jiupei Tadalafil Film
Indications: treatment of Erectile dysfunction (ED).
Products And Services
Products And Services
Products and services
Products and services
Youngsure ®Orlistat Capsules
For the treatment of obese or overweight patients (body mass index≥24)
Youngsure ®Orlistat Capsules
For the treatment of obese or overweight patients (body mass index≥24)
Donepezil Hydrochloride Tablets
Indication: For the treatment of minor, moderate or severe symptoms of Alzheimer’s disease.
Ropinirole Hydrochloride Tablets
Indication: This product is suitable to treat the symptoms and signs of Primary Parkinson’s disease in combination with levodopa.
Suplatast Tosilate Granules
Indication: This product is suitable for the treatment of bronchial asthma
Geruishu® Metformin Hydrochloride Sustained-release Tablets
Indication: This product is recommended as a stand-alone treatment in combination with diet and exercise therapy to achieve glycemic control in type 2 diabetes. It can be used in combination with sulfonylureas and insulin to control blood glucose in adults.
Lingsu® Quetiapine Fumarate Sustained-Release Tablets
Indication: This product is used for the treatment of depressive episodes in schizophrenia and bipolar disorder.
Ali® Orlistat Capsules
Superiormechanism:lipaseinhibitor,inhibitsfatabsorptioninthediet.Highsafety:non-centralnervousactionweightreductiondrug,noeffectofappetitesuppression;minimallyabsorptionintothebloodstream.Significante
Saige’en ® Tropisetron Hydrochloride Injection
Indication: Prevent nausea and vomiting caused by cancer chemotherapy; treat nausea and vomiting after surgery.
Miconazole Nitrate Suppository
Indication: Topical treatment of dual infections caused by Candida vulvovaginosis and Gram-positive bacteria.
Youngsure ® Orlistat Capsules
Indication: For the treatment of obese or overweight patients (body mass index≥24)
Strength: 120mg
Package: Aluminum foil for drug package, PVC sheet for packing solid medicine, 3 capsules/blister*1 blister/carton, 18 capsules/blister*1 blister/carton, etc.
Validity: 36 months
Approval Number: National Medicine Standard H20123131
-Superior mechanism: Lipase inhibitor that acts by inhibiting the absorption of dietary fats.
-Better safety: Non-central nervous action weight reduction drug, no effect of appetite suppression; minimally absorption into the bloodstream.
-Significant effects: Effectively reduce body fat, significantly reduce waist circumference, and improve related risk factors.
Purchasing Channels
微信公众号